Rebiopsy of Lung Cancer Patients with Acquired Resistance to EGFR Inhibitors and Enhanced Detection of the T790M Mutation Using a Locked Nucleic Acid-Based Assay
Maria E. Arcila(Memorial Sloan Kettering Cancer Center), Marc Ladanyi(Memorial Sloan Kettering Cancer Center), Mark G. Kris(Memorial Sloan Kettering Cancer Center), Geoffrey R. Oxnard(Foundation Medicine (United States)), Gregory J. Riely(Memorial Sloan Kettering Cancer Center), William Pao(Albany Medical Center Hospital), Maureen F. Zakowski(Memorial Sloan Kettering Cancer Center), Stephen B. Solomon(Memorial Sloan Kettering Cancer Center), Vincent A. Miller(Universidad San Carlos), Khédoudja Nafa(Memorial Sloan Kettering Cancer Center)
Cited by 574
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer
|New England Journal of Medicine|2013|3.4k